Objective: To describe the diagnostic, therapeutic and
evolutionary aspects of the CTIN cases treated in our department.
Patients and
Method: We conducted a
descriptive and analytical retrospective study of CTIN cases treated in the
only paediatric nephrology department in Senegal between January 2015 and
December 2022. The data collected were analysed with SPSS version 21 software.
Results: After data collection, 64 children were included
during the study period, corresponding to a hospital prevalence of 9% (64/709)
of the chronic kidney disease (CKD) monitored in our department. The average
age of the children at the onset of the disease was 5.5 ± 5.3 years. The gender
ratio (M/F) was 2.4 (45/19). The reasons for consultation were lumbar pain
28.1% (18/64), hypertension 17.2% (11/64), fever 15.6% (10/64),
polyuropolydipsia 12.5% (8/64), proteinuria 12.5% (n=8), abacterial
leukocyturia 6.2% (4/64) and hematuria 3% (2/64). Ultrasound examination
revealed nephrocalcinosis in 43.9% (28/64) of cases. A renal biopsy was
performed in 6.2% (4/64) of patients, confirming typical CTIN lesions.
Crystalluria testing identified revealed uric acid in one case and a cystine
calculus in another. Genetic testing was performed in 4.6% (3/64) of the
children with 01 claudin-16 mutation, and 02 cases of familial mutation of the
CTNS gene. Hereditary tubulopathies accounted for 53.1% (34/64) of the causes
of CTINs, followed by reflux nephropathy 18.8% (12/64). The hospital mortality
rate was 6.2% (4/64). Death was related to the development of CKD to dialysis
stage V (p=0,001).
Conclusion: In our study, CTINs accounted for less than one tenth
of the causes of CKD in children. Limited access to genetics and specific blood
and urine tests was the major limitation in this study. Therefore, there is a
need to provide diagnostic tools for CTIN in Dakar.